These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19937096)

  • 1. Late thromboembolic events after circumferential pulmonary vein ablation of atrial fibrillation.
    Tao H; Ma C; Dong J; Liu X; Long D; Yu R
    J Interv Card Electrophysiol; 2010 Jan; 27(1):33-9. PubMed ID: 19937096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry.
    Kornej J; Kosiuk J; Hindricks G; Arya A; Sommer P; Rolf S; Husser D; Lip GY; Bollmann A
    Clin Res Cardiol; 2015 Jul; 104(7):603-10. PubMed ID: 25707763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term incidence and predictive factors of thromboembolic events after a cryoballoon ablation for atrial fibrillation.
    Hermida A; Zaitouni M; Diouf M; Lallemand PM; Fay F; Buiciuc O; Kubala M; Hermida JS
    Int J Cardiol; 2020 Dec; 321():99-103. PubMed ID: 32810541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation.
    Nedios S; Kornej J; Koutalas E; Bertagnolli L; Kosiuk J; Rolf S; Arya A; Sommer P; Husser D; Hindricks G; Bollmann A
    Heart Rhythm; 2014 Dec; 11(12):2239-46. PubMed ID: 25128733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy.
    Duytschaever M; Berte B; Acena M; De Meyer G; Bun SS; Van Heuverswyn F; Vandekerckhove Y; Tavernier R
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):855-60. PubMed ID: 23600918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical characteristics of transient ST-T elevation during transseptal catheterization for atrial fibrillation ablation.
    Tang RB; Dong JZ; Long DY; Yu RH; Liu XP; Cheng YL; Sang CH; Ning M; Jiang CX; Avula UM; Bai R; Liu N; Ruan YF; Du X; Ma CS
    Europace; 2015 Apr; 17(4):579-83. PubMed ID: 25349227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of very late recurrence of atrial fibrillation after circumferential pulmonary vein ablation.
    Tao H; Liu X; Dong J; Long D; Tang R; Zheng B; Kang J; Yu R; Tian Y; Ma C
    Clin Cardiol; 2008 Oct; 31(10):463-8. PubMed ID: 18855350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation.
    Gaita F; Sardi D; Battaglia A; Gallo C; Toso E; Michielon A; Caponi D; Garberoglio L; Castagno D; Scaglione M
    Europace; 2014 Jul; 16(7):980-6. PubMed ID: 24446510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation.
    Liu J; Fang PH; Dibs S; Hou Y; Li XF; Zhang S
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):398-406. PubMed ID: 21091744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of multielectrode-phased radiofrequency pulmonary vein ablation catheter and irrigated radiofrequency catheter.
    Wasmer K; Foraita P; Leitz P; Güner F; Pott C; Lange PS; Eckardt L; Mönnig G
    Europace; 2016 Jan; 18(1):78-84. PubMed ID: 25883082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation.
    Tran VN; Tessitore E; Gentil-Baron P; Jannot AS; Sunthorn H; Burri H; Mach F; Shah D
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):499-506. PubMed ID: 25626468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up.
    Medi C; Sparks PB; Morton JB; Kistler PM; Halloran K; Rosso R; Vohra JK; Kumar S; Kalman JM
    J Cardiovasc Electrophysiol; 2011 Feb; 22(2):137-41. PubMed ID: 20812937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.
    Ukaigwe A; Shrestha P; Karmacharya P; Hussain SK; Samii S; Gonzalez MD; Wolbrette D; Naccarrelli GV
    J Interv Card Electrophysiol; 2017 Mar; 48(2):223-233. PubMed ID: 27771820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incremental benefit of non-pulmonary vein left atrial ablation in patients undergoing a repeat persistent atrial fibrillation ablation procedure.
    Goldenberg GR; Ono M; Aryana A; d'Avila A; Saad EB; Singh SK; Singh SM
    J Interv Card Electrophysiol; 2017 Mar; 48(2):185-191. PubMed ID: 27766514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late relapse of atrial fibrillation after pulmonary vein isolation: incidence and results of repeat ablation.
    Fichtner S; Czudnochowsky U; Hessling G; Reents T; Estner H; Wu J; Jilek C; Ammar S; Karch MR; Deisenhofer I
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1258-63. PubMed ID: 20528996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and Characteristics of Multiple (More Than 2) Catheter Ablation Procedures for Atrial Fibrillation.
    Lo LW; Lin YJ; Chang SL; Hu YF; Chao TF; Chung FP; Liao JN; Chiou CW; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1048-56. PubMed ID: 26178628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure.
    Mulder AA; Wijffels MC; Wever EF; Boersma LV
    Europace; 2012 Jun; 14(6):818-25. PubMed ID: 22345375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.